Ted Knous
Directeur/Membre du Conseil chez University of Kansas
Postes actifs de Ted Knous
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Kansas | Directeur/Membre du Conseil | 31/03/2009 | - |
Historique de carrière de Ted Knous
Anciens postes connus de Ted Knous
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Igxbio, Inc.
 Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Directeur/Membre du Conseil | 31/03/2009 | - |
Formation de Ted Knous
| University of Minnesota | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Igxbio, Inc.
Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Health Technology |
